Close Menu

macular degeneration

IP Update: Apr 23, 2009

Premium

USPTO Publishes Two Patents, Sixteen Patent Applications Related to RNAi

IP Update: Apr 16, 2009

Premium

USPTO Publishes Two Patents, 13 Patent Applications Related to RNAi

People Transfer: Apr 15, 2009

Premium

Burrill promotes Aynechi, Vygantas, and Patel; UVA Patent Foundation honors Mugler and Brookeman as inventors of the year; and Balser to succeed Jacobson as vice chancellor for health affairs at Vanderbilt

The data demonstrate that siRNAs that are 21 nucleotides in length or longer suppress both hemangiogenesis and lymphangiogenesis in vivo, regardless of their targets or sequences, due to the activation of TLR3.

Although the future of the drug is unclear, an Opko executive said that the firm remains committed to its portfolio of VEGF-targeting siRNAs.

The Umbrella Institute

Premium

The Hunter Medical Research Institute was started to bring together biomedical and clinical scientists — and the results have been so positive that it has become a model for how to accomplish translational research.

Based on their assessment of SNP data for several complex diseases, researchers from the University of Pittsburgh and the University of California at Los Angeles warn that genetic tests based on existing GWAS may not be refined enough to accurately predict individual disease risk.

Navigenics’ lower-priced program to incorporate genetic risk data in patients’ annual medical checkup raises questions as to whether personal genomics firms should be broadly marketing their services to physicians.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.